Day: December 5, 2022

HilleVax Announces Positive Immunogenicity Results for Run-In Cohort of NEST-IN1 Phase 2b Clinical Trial of HIL-214 Norovirus Vaccine Candidate

Written by Customer Service on December 5, 2022. Posted in Public Companies.

BOSTON, Dec. 05, 2022 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported results from a prespecified immunogenicity analysis of the 203 subjects enrolled in the run-in cohort of NEST-IN1 (Norovirus Efficacy and Safety Trial for INfants), the company’s ongoing Phase 2b trial for HIL-214, its investigational virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe norovirus-related acute gastroenteritis (AGE) in infants. These results follow the previously announced positive recommendation from an independent safety data monitoring committee based on this same cohort. Immunogenicity Results:Geometric Mean Titers (GMTs) of pan-IG antibodies 28 days following the second dose were 11,102.0...

Veru Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results

Written by Customer Service on December 5, 2022. Posted in Public Companies.

U.S. FDA reviewing EUA application for sabizabulin to treat hospitalized COVID-19 patients at high risk for ARDS European Medicines Agency’s (EMA) Emergency Task Force reviewing sabizabulin for emergency use in EU member states Sabizabulin also under review for potential emergency authorization by MHRA (UK), TGA (Australia), and Health Canada Veru preparing for U.S. and international commercialization and distribution of sabizabulin, and manufacturing capacity for drug supply in place Company to host conference call and webcast today at 8:00 a.m. ET MIAMI, FL, Dec. 05, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for oncology, today announced financial results for its fiscal 2022 fourth quarter and full...

Wireless Telecom Group Announces the Sale of CommAgility, its Radio, Baseband and Software Segment, to E-Space

Written by Customer Service on December 5, 2022. Posted in Public Companies.

Parsippany, New Jersey, USA, Dec. 05, 2022 (GLOBE NEWSWIRE) — Wireless Telecom Group, Inc. (NYSE American: WTT) (the “Company”) today announced it entered into a definitive agreement to sell its radio, baseband and software segment, CommAgility LTD., to global space company, E-Space. The purchase price is $14.5 million, inclusive of $13.75 million in cash consideration and a $750,000 note payable, subject to agreed-upon reductions. The transaction was the result of the Company’s previously disclosed process for evaluating strategic alternatives. The Purchase Agreement includes customary terms and conditions, including certain adjustments to the purchase price based on transaction costs, net working capital and indebtedness. The transaction, which was unanimously approved by the Board of Directors of both companies, is subject to...

TFF Pharmaceuticals Announces Leadership Transition

Written by Customer Service on December 5, 2022. Posted in Public Companies.

Glenn Mattes to step down as Chief Executive Officer and as a Member of the Board of Directors Dr. Harlan F. Weisman, Vice Chairman of the Board, appointed as Interim Chief Executive Officer FORT WORTH, Texas, Dec. 05, 2022 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, today announced that Glenn Mattes will step down as Chief Executive Officer and Member of the Board of Directors. Dr. Harlan F. Weisman, Vice Chairman of the Board, has been appointed Interim Chief Executive Officer, effective December 5, 2022. “On behalf of the entire Board of Directors and our shareholders, I would like to thank Glenn for his leadership and accomplishments,” said...

With 15.1% CAGR, Orthokeratology Lens Market Size to Surpass Around USD 2,043.6 Billion by 2029

Written by Customer Service on December 5, 2022. Posted in Mergers And Acquisitions.

According to Fortune Business Insights, Orthokeratology Lens Market to Reach USD 2,043.6 Billion by 2029; Increasing Awareness Regarding the Benefits Associated with the Lens to Propel Industry Growth Pune, India, Dec. 05, 2022 (GLOBE NEWSWIRE) — The global orthokeratology lens market size was valued at USD 683.5 million in 2021. The market is expected to grow from USD 763.9 million in 2022 to USD 2,043.6 million by 2029, exhibiting a CAGR of 15.1% during the forecast period. The increasing prevalence of refractive errors among the population and rising awareness regarding the lenses’ benefits are expected to enhance the market growth. Fortune Business Insights™ presents this information in its report titled “Orthokeratology Lens Market, 2022-2029.”Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/orthokeratology-lens-market-103110Key...

Waterjet Cutting Machines Market Size to Hit USD 1,675.1 Million by 2027 | Exhibit a CAGR of 6.3%

Written by Customer Service on December 5, 2022. Posted in Mergers And Acquisitions.

The global waterjet cutting machines market size was valued USD 1,036.9 million in 2019. The global market size is projected to reach USD 1,675.1 Million by 2027; it is estimated to grow at a CAGR of 6.3% from 2020 to 2027. Pune, India, Dec. 05, 2022 (GLOBE NEWSWIRE) — The global waterjet cutting machines market size is expected to grow from USD 1,036.9 million in 2019 and is projected to reach USD 1,675.1 Million by 2027, exhibiting a CAGR of 6.3% during the forecast period from 2020-2027. This information is provided by Fortune Business Insights, in its report, titled, “Waterjet Cutting Machines Market, 2020-2027.” According to our analysts, the market size is set to gain momentum from the rising need for quick diagnosis of the consumer’s problems. Companies are trying to fix them in real-time. They are also focusing more on...

With 10.9% CAGR, Embedded Security Market Size worth USD 17.03 Billion in 2029

Written by Customer Service on December 5, 2022. Posted in Mergers And Acquisitions.

As per the report by Fortune Business Insights, the global Embedded Security Market size is projected to reach USD 17.03 billion in 2029, at a CAGR of 10.9% during the forecast period, 2022-2029 Pune, India, Dec. 05, 2022 (GLOBE NEWSWIRE) — The global Embedded Security Market Size was valued at USD 8.04 billion in 2021. The market is expected to grow from USD 8.23 billion in 2022 to USD 17.03 billion in 2029, exhibiting a CAGR of 10.9% over the estimated period. The surge can be attributed to the emergence of industrial automation and IoT. This information is provided by Fortune Business Insights™ in its research report, titled “Embedded Security Market, 2022-2029”.Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/embedded-security-market-103738Key Industry...

Hepsor AS financial calendar 2023

Written by Customer Service on December 5, 2022. Posted in Public Companies.

In 2022, Hepsor AS plans to disclose the consolidated financial results as follows:15 February 2023 Unaudited interim report for Q4 and 12 months 202228 April 2023 Audited annual report for 202210 May 2023 Unaudited interim report for first three months 202326 July 2023 Unaudited interim report for six months and Q2 20231 November 2023 Unaudited interim report for nine months and Q3 2023The annual general meeting of shareholders for 2022 financial year will be held in the second quarter of 2023. The exact time and location will be specified accordingly. Anneli SimmHead of Investor RelationsPhone: +372 5615 7170e-mail: anneli@hepsor.ee Hepsor AS (www.hepsor.ee) is one of the fastest growing residential and commercial real estate developers in Estonia and Latvia. Over the last eleven years Hepsor...

Kering: Press release – Disclosure of transactions in own shares – November 28 to December 02, 2022

Written by Customer Service on December 5, 2022. Posted in Public Companies.

Paris, December 05, 2022, Disclosure of Transactions in Own Shares In accordance with the authorization given by the shareholders’ annual meeting on April 28, 2022 to trade on its own shares and pursuant to applicable law on share repurchase, Kering (LEI: 549300VGEJKB7SVUZR78) declares the following purchases of its own shares (FR0000121485) from November 28 to December 02, 2022: Issuer’s name Issuer’s identifying code Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares Market (MIC code)KERING 549300VGEJKB7SVUZR78 28/11/2022 FR0000121485 8,147 543.8505 XPARKERING 549300VGEJKB7SVUZR78 28/11/2022 FR0000121485 1,483 544.1813 CEUXKERING 549300VGEJKB7SVUZR78 28/11/2022...

Serstech welcomes new CFO

Written by Customer Service on December 5, 2022. Posted in Public Companies.

Simon Persson will join Serstech as Chief Financial Officer on March 1, 2023. Simon has several years of experience from the auditing industry as Senior Associate at EY and has a strong background from working with growth companies. Simon most recently comes from Quicktest Scandinavia, where he held the role of CFO. Simon has a master’s degree in business and economics from Linnaeus University.For further information, please contact: Stefan Sandor,CEO, Serstech ABPhone: +46 739 606 067Email: ss@serstech.com Thomas Pileby,Chairman of the Board, Serstech ABPhone: +46 702 072 643Email: tp@serstech.com or visit: www.serstech.com Certified advisor to Serstech is Svensk Kapitalmarknadsgranskning AB (SKMG). About Serstech Serstech delivers solutions for chemical identification and has customers around the world, mainly in the safety and security...

Day: December 5, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice